Jove
Visualize
Contact Us

Related Experiment Videos

Viper venom components affecting angiogenesis.

T F Huang1, C H Yeh, W B Wu

  • 1Pharmacological Institute, College of Medicine, National Taiwan University, No. 1 Jen-Ai Road, Sec. 1, Taipei, Taiwan, ROC. turfu@ccms.ntu.edu.tw

Haemostasis
|March 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Improving chemotherapy-induced peripheral neuropathy in cancer patients using a combined qigong and self-administered acupressure intervention: a randomized controlled trial': [ESMO Open Volume 10, Issue 9, September 2025, 105565].

ESMO open·2025
Same author

Improving chemotherapy-induced peripheral neuropathy in cancer patients using a combined qigong and self-administered acupressure intervention: a randomized controlled trial.

ESMO open·2025
Same author

New Limits on the Coherent Neutrino-Nucleus Elastic Scattering Cross Section at the Kuo-Sheng Reactor-Neutrino Laboratory.

Physical review letters·2025
Same author

Constraints on Sub-GeV Dark Matter-Electron Scattering from the CDEX-10 Experiment.

Physical review letters·2022
Same author

Development of the Soft X-ray AGM-AGS RIXS beamline at the Taiwan Photon Source.

Journal of synchrotron radiation·2021
Same author

[Correlation between spatial navigation disorder and white matter hyperintensity in patients with mild cognitive impairment].

Zhonghua yi xue za zhi·2020
Same journal

Thrombosis and Haemostasis Issues in Cancer. International Conference. Bergamo, Italy, 2-4 November 2001. Lectures and abstracts.

Haemostasis·2002
Same journal

Biochemistry of cancer procoagulant.

Haemostasis·2002
Same journal

Management of thromboembolic disease in cancer patients.

Haemostasis·2002
Same journal

An overview of thromboprophylaxis in malignancy.

Haemostasis·2002
Same journal

Platelets cross-talk with tumor cells.

Haemostasis·2002
Same journal

Properties and function of heparanase in cancer metastasis and angiogenesis.

Haemostasis·2002
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Rhodostomin, a disintegrin, effectively inhibits angiogenesis by blocking endothelial cell functions and tumor neovascularization. This compound suppressed tumor growth and improved survival in mice, highlighting its potential as an anti-cancer therapeutic.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Angiogenesis, the formation of new blood vessels, is crucial for solid tumor progression.
  • Disintegrins and glycoprotein-IIb/IIIa-binding proteins are investigated for their anti-angiogenic properties.

Purpose of the Study:

  • To evaluate the effects of disintegrins, specifically rhodostomin and accutin, on endothelial cell functions and angiogenesis.
  • To assess the in vitro and in vivo anti-angiogenic and anti-tumor efficacy of rhodostomin.

Main Methods:

  • In vitro assays using human umbilical vein endothelial cells (HUVECs) to assess viability, capillary tube formation, migration, and invasion.
  • In vivo studies using the chick chorioallantoic membrane model and B16F10 melanoma tumor models in mice.
  • Evaluation of neovascularization, tumor growth, and animal survival.

Related Experiment Videos

Main Results:

  • Rhodostomin inhibited HUVEC viability, capillary tube formation, migration, and invasion induced by basic fibroblast growth factor (bFGF).
  • In vivo, rhodostomin suppressed bFGF- and B16F10 melanoma cell-induced angiogenesis, reduced tumor growth, and prolonged mouse survival.
  • Agkistin did not exhibit significant anti-angiogenic effects.

Conclusions:

  • Rhodostomin demonstrates potent anti-angiogenic and anti-tumor activities.
  • Its mechanism may involve blocking the interaction between endothelial αvβ3 integrin and extracellular matrix.
  • Rhodostomin shows promise as a therapeutic agent for inhibiting tumor angiogenesis and growth.